|
Tuberculosis, Pulmonary
|
C01.748.939 |
|
|
Fatty Acid Synthases
|
D08.811.520.241.300.287 |
|
|
Phytochrome A
|
D23.767.712.249 |
|
|
Leishmaniasis, Cutaneous
|
C01.920.813.400 |
|
|
Leishmaniasis
|
C01.920.813 |
|
|
Islands of Calleja
|
A08.186.211.200.885.287.750.656.500 |
|
|
Olfactory Tubercle
|
A08.186.211.200.885.287.750.656 |
|
|
Staphylococcus capitis
|
D000074039 |
[A COAGULASE-negative species of STAPHYLOCOCCUS found on the skin and MUCOUS MEMBRANE of warm-blooded animals. Similar to STAPHYLOCOCCUS EPIDERMIDIS and STAPHYLOCOCCUS HAEMOLYTICUS, it is a nosocomial pathogen in NICU settings. Subspecies include generally antibiotic susceptible and BIOFILM negative capitis and antibiotic resistant and biofilm positive urealyticus isolates.
] |
|
Fracture Dislocation
|
C05.550.518.336 |
|
|
Dermatologists
|
N02.360.810.215 |
|
|
Maple Syrup Urine Disease
|
C10.228.140.163.100.520 |
|
|
Chromosomes, Human, Pair 3
|
G05.360.162.520.300.235.250 |
|
|
Chromosomes, Human, 1-3
|
G05.360.162.520.300.235 |
|
|
Vasculitis, Central Nervous System
|
C10.114.875 |
|
|
Receptors, Histamine H4
|
D000074040 |
[G-Protein-coupled histamine receptors that are expressed primarily in BONE MARROW as well as in peripheral tissues and organs. They are expressed by immune cells that include EOSINOPHILS; T-CELLS; DENDRITIC CELLS; and MAST CELLS.
] |
|
Complement Factor I
|
D08.811.277.656.959.350.210 |
|
|
Microorganisms, Genetically-Modified
|
D000074041 |
[Microorganisms whose GENOME has been altered by GENETIC ENGINEERING.
] |
|
Receptor Activity-Modifying Protein 1
|
D12.776.543.725.100 |
|
|
Receptor Activity-Modifying Proteins
|
D12.776.543.725 |
|
|
Cerebral Intraventricular Hemorrhage
|
D000074042 |
[Bleeding within the CEREBRAL VENTRICLES. It is associated with intraventricular trauma, aneurysm, vascular malformations, hypertension and in VERY LOW BIRTH WEIGHT infants.
] |
